Skip to main content
OpenTrials
Completed

NCT Number: NCT02082171

Multidomain Intervention to Prevent Disability in Elders

Prevention of physical disability represents a major priority for the public health system. Physical disability is the final result of a complex cascade of negative events occurring at different levels (i.e., environmental, social, biological, and clinical). The heterogeneity of the underlying mechanisms responsible for the onset of physical disability may require the adoption of preventive interventions affecting multiple domains. Although several studies suggest that single or different combinations of preventive interventions (in particular, physical activity, cognitive training, and healthy diet) might provide beneficial effects in preventing functional loss (and its related features, such as pain or reduced quality of life), very limited evidence coming from clinical trials is currently available on the topic. Intervention trials are usually designed to test the effect of a specific monodimensional intervention on a very selected population, so to reduce the risk of biased results. This approach, although legitimate and methodologically correct, may 1) be insufficient to target the multiple and heterogeneous physiopathological mechanisms underlying the onset of physical disability, and 2) cause a population selection bias leading to difficulties in implementing the study results to the overall older population (thus, determining the "evidence-based medicine" issue in the elderly). To our knowledge, there are no available data from clinical trials evaluating the effects of a multidomain intervention based on lifestyle modifications (e.g., physical activity, cognitive training, nutritional modification) for preventing mobility disability (a very early phase of the disabling process) in community-dwelling older persons. In the present project (Multidomain Intervention to preveNt Disability in ElDers, MINDED), we propose to conduct a pilot study aimed at estimating the effects of a multidomain person-tailored preventive intervention (based on physical activity, cognitive training, and nutritional modifications) on frailty status, physical performance, cognitive function, nutritional status, health-related quality of life, and use of health care services. In addition, we will perform cost-effectiveness analyses of the proposed intervention. The project will yield the necessary preliminary data to design a definitive full-scale Phase 3 randomized clinical trial. By providing a conclusive answer about the effectiveness of a multidimensional preventive program in the primary prevention of major health-related outcomes, the results of the full-scale trial will have relevant clinical and public health implications, and will promote the practicing of a truly evidence-based geriatric medicine.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre de Rééducation Fonctionnelle "La Roseraie"

Montfaucon, 46240, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of 60 years and older;
  • Willingness to be randomized to either treatment group;
  • Pre-frailty or frailty status according to the phenotype described by Fried and colleagues

Exclusion criteria

  • Failure to provide informed consent;
  • Inability to complete a 400-meter walk test (primary outcome of the study);
  • Living in nursing home;
  • Living outside of the area of interest, or planning to move out of the area in next 3 years, or planning to leave the area for more than 3 months during the next year;
  • Relevant cognitive impairment (defined as a known diagnosis of dementia);
  • Severe progressive, degenerative neurologic disease (e.g., multiple sclerosis);
  • Severe rheumatologic or orthopaedic diseases (e.g., awaiting joint replacement);
  • Terminal illness with life expectancy less than 12 months;
  • Severe pulmonary disease (e.g., oxygen therapy or chronic use of steroids);
  • Severe cardiac disease (e.g., New York Heart Association Class III or IV heart failure, clinically significant aortic stenosis, history of cardiac arrest, uncontrolled angina);
  • Other significant comorbid conditions that would impair the ability to participate in the multidomain intervention (e.g., renal failure on hemodialysis, severe psychiatric disorder, excessive alcohol use). To be noted: persons with depression will not be excluded.

Treatment and study plan

Multidomain intervention

Other

Multidomain preventive intervention designed by a multidisciplinary team on the basis of results of a comprehensive geriatric assessment

Primary outcomes

  1. 400-meter walk test

    Time frame: 12 months

    Incident inability to complete the 400-meter walk test in the two randomization groups

Secondary outcomes

  1. Participants' adherence/retention to the intervention protocol and control groups

    Time frame: 12 months

    Participants' adherence/retention to the intervention protocol

  2. Intercurrent illnesses rates

    Time frame: 12 months

    Intercurrent illnesses rates in the two randomization groups

  3. Serious fall injuries

    Time frame: 12 months

    Incident fall injuries occurred in the two randomization groups

  4. Hospitalizations and institutionalization rates

    Time frame: 12 months

    Incidence of acute care hospitalizations and nursing home admissions in the two randomization groups

  5. Mortality

    Time frame: 12 months

    Overall mortality rate in the two randomization groups

  6. Health-related quality of life

    Time frame: 12 months

    Modifications of health-related quality of life in the two randomization groups

  7. Body composition modifications

    Time frame: 12 months

    Body composition modifications (assessed using bioimpedance analysis) in the two randomization groups

  8. Modification of Pain

    Time frame: 12 months

    Modification of pain symptoms in the two randomization groups

  9. Fatigue

    Time frame: 12 months

    Modification of the fatigue symptom in the two randomization groups

Sponsors and collaborators

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Other Gov

Collaborators

  • National Research Agency, France

Registry information

Acronym: MINDED

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Mar 10, 2014
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.